UpHealth (UPH) to Release Earnings on Thursday

UpHealth (NYSE:UPH – Get Rating) will be releasing its earnings data before the market opens on Thursday, May 12th. Analysts expect UpHealth to post earnings of ($0.05) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

UpHealth stock opened at $0.82 on Thursday. UpHealth has a twelve month low of $0.73 and a twelve month high of $10.72. The company has a current ratio of 1.10, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30. The company has a 50 day moving average of $1.56 and a 200-day moving average of $2.08.

Several research firms have recently weighed in on UPH. Lake Street Capital cut shares of UpHealth from a “buy” rating to a “hold” rating in a report on Thursday, March 31st. Northland Securities reduced their price target on shares of UpHealth from $10.50 to $4.50 and set an “outperform” rating for the company in a report on Thursday, March 31st. Finally, Zacks Investment Research upgraded shares of UpHealth from a “sell” rating to a “hold” rating in a report on Tuesday, April 26th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $9.63.

A number of institutional investors and hedge funds have recently made changes to their positions in UPH. Morgan Stanley acquired a new position in UpHealth during the second quarter worth $75,000. Bank of America Corp DE acquired a new stake in UpHealth in the second quarter valued at $178,000. Cubist Systematic Strategies LLC lifted its stake in UpHealth by 169.7% in the third quarter. Cubist Systematic Strategies LLC now owns 31,284 shares of the company’s stock valued at $99,000 after acquiring an additional 19,684 shares during the last quarter. Millennium Management LLC acquired a new stake in UpHealth in the third quarter valued at $246,000. Finally, Northern Trust Corp acquired a new stake in UpHealth in the fourth quarter valued at $280,000. Institutional investors and hedge funds own 13.05% of the company’s stock.

UpHealth Company Profile (Get Rating)

UpHealth, Inc operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; Global Telemedicine; MedQuest Digital Pharmacy, a full-service pharmacy that offers manufactured medication, custom compounded medications, nutraceuticals, lab testing, advocacy, education, etc.; and Behavioral Telehealth solutions.

Recommended Stories